Dr. Benjamin M. Manning, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Minnesota Medical School (2017)
- Years since graduation
- 9
- In the NPI registry since
- 2017
- Medicare patients seen, 2024
- 76
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2017Medical school: University of Minnesota Medical School
- 2017Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
MN license 73979 -
Internal Medicine Physician
MN license 73979
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- M Health Fairview University of Mn Medical Center Minneapolis, MN
- M Health Fairview Southdale Hospital Edina, MN
- M Health Fairview St John's Hospital Maplewood, MN
- M Health Fairview Ridges Hospital Burnsville, MN
- Fairview Lakes Health Services Wyoming, MN
Medical groups
- Fairview Express Care (1,911 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 76
- Services billed
- 389
- Patients’ average age
- 71
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prochlorperazine Maleate Other prescribers in Minneapolis, MN | 38 |
| Dexamethasone Other prescribers in Minneapolis, MN | 29 |
| Ondansetron Hcl Other prescribers in Minneapolis, MN | 24 |
| Levothyroxine Sodium Other prescribers in Minneapolis, MN | 22 |
| Prednisone Other prescribers in Minneapolis, MN | 17 |
| Methylprednisolone Other prescribers in Minneapolis, MN | 16 |
| Tagrisso (osimertinib mesylate) | 12 |
| Oxycodone Hcl Other prescribers in Minneapolis, MN | 12 |
| Lorazepam Other prescribers in Minneapolis, MN | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $146 in total to this clinician.
| Delcath Systems | $146 |
|---|
| Food and Beverage | $146 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 1 companies. The companies reported $188,143 in research payments for these studies, mostly to the institutions running them.
- Study name not reported
Iovance Biotherapeutics, Inc. - NCT02360579
Iovance Biotherapeutics, Inc. - Study name not reported
Iovance Biotherapeutics, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.